Cardiomedex
  • home
  • About us
    • Corporate overview
    • Team
    • Ethics and Quality
    • Partners
  • CRO services
    • In vivo models
    • In vivo exploration
    • Ex vivo / in vitro assays
    • Molecular screening
  • Consulting services
  • News publications
    • Conference
    • Scientific Publications
  • Contact Us
  • Careers
Sélectionner une page
Physiogenex and Cardiomedex to present the SDT fatty rat model at ISN-World Congress of Nephrology in Bangkok, Thailand, March 30-April 2, 2023

Physiogenex and Cardiomedex to present the SDT fatty rat model at ISN-World Congress of Nephrology in Bangkok, Thailand, March 30-April 2, 2023

par Rana ASSALY | Avr 24, 2023 | conference

Physiogenex, its subsidiary company Cardiomedex, and its partner CLEA Japan Inc., will be presenting their collaborative work at the ISN-World Congress of Nephrology, to be held March 30-April 2 in Bangkok, Thailand. Dr. François Briand, Director of Research and...
Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference on type 2 Diabetes therapeutics, May 1-4 in Palm Springs, CA, USA

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference on type 2 Diabetes therapeutics, May 1-4 in Palm Springs, CA, USA

par Rana ASSALY | Avr 24, 2023 | conference

Physiogenex and its subsidiary company Cardiomedex will be presenting a new diabetic NASH HFpEF hamster model at the Keystone Symposia on type 2 diabetes therapeutics in Palm Springs, CA, USA May 1-4, 2023. This unique preclinical model will be presented during the...

Articles récents

  • Cardiomedex to present NASH hamster model at the AHA 2023
  • Cardiomedex to present a HFpEF hamster model at the 37thAnnual Meeting of the International Society of Heart Research (ISHR)July 10th-13th in Porto,Portugal
  • Physiogenex and Cardiomedex to present the SDT fatty rat model at ISN-World Congress of Nephrology in Bangkok, Thailand, March 30-April 2, 2023
  • Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference on type 2 Diabetes therapeutics, May 1-4 in Palm Springs, CA, USA

Commentaires récents

    logo cardiomedex

    Cardiomedex is a preclinical CRO that is highly specialized in cardiovascular diseases and complications. Cardiomedex provides a wide choice of benchmarked animal models targeting heart failure with preserved or reduced ejection fraction, myocardial infarction, cardiac hypertrophy, hypertension, and anthracycline cardiotoxicity. We also offer ex vivo and in vitro models for drug development and pharmacological research. We have a decade of experience in evaluating the efficacy of our clients’ drugs using gold-standard and tailor-made experiments and our large selection of validated preclinical assays.

     

    For more information on our company and offers, please download our Corporate Presentation.

    Menu

    • CRO services
    • Consulting services
    • Scientific Publications
    • Contact Us

    Services

    • In vivo models
    • In vivo exploration
    • Ex vivo / in vitro exploration
    • Molecular screening

    Useful Menu

    • Home
    • Contact Us
    • Legal Mentions
    • Privacy Policy

    Contact

    CARDIOMEDEX

    Address: 280 rue de l’Hers, ZAC de la Masquère, 31750 Escalquens – France
    Phone: +33532097980

    For general inquiries, please contact us here.

    • Twitter
    • Linkedin
    • Viadeo
    Copyright © CARDIOMEDEX